1. 2022
  2. Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): study protocol for a randomised phase III trial

    Janssen, J., Staal, F. H. E., Brouwer, C. L., Langendijk, J. A., de Jong, I. J., van Moorselaar, R. J. A., Schuit, E., Verzijlbergen, J. F., Smeenk, R. J. & Aluwini, S., 1 Dec 2022, In: BMC cancer. 22, 1, 482.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation

    Hentschel, A. E., Beijert, I. J., Bosschieter, J., Kauer, P. C., Vis, A. N., Lissenberg-Witte, B. I., van Moorselaar, R. J. A., Steenbergen, R. D. M. & Nieuwenhuijzen, J. A., 1 Dec 2022, In: Clinical epigenetics. 14, 1, 19.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer

    de Ruiter, B-M., van Hattum, J. W., Lipman, D., de Reijke, T. M., van Moorselaar, R. J. A., van Gennep, E. J., Maartje Piet, A. H., Donker, M., van der Hulle, T., Voortman, J., Oddens, J. R., Hulshof, M. C. C. M. & Bins, A. D., Nov 2022, In: European urology. 82, 5, p. 518-526 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer

    Holleman, M. S., Huygens, S. A., Al, M. J., Kuppen, M. C. P., Westgeest, H. M., van den Bergh, A. C. M., Bergman, A. M., van den Eertwegh, A. J. M., Hendriks, M. P., Lampe, M. I., Mehra, N., van Moorselaar, R. J. A., van Oort, I. M., Somford, D. M., de Wit, R., van de Wouw, A. J., Gerritsen, W. R. & Groot, C. A. U., Jun 2022, In: Drugs - real world outcomes. 9, 2, p. 275-285 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer

    Bodar, Y. J. L., Veerman, H., Meijer, D., de Bie, K., van Leeuwen, P. J., Donswijk, M. L., van Moorselaar, R. J. A., Hendrikse, N. H., Boellaard, R., Oprea-Lager, D. E. & Vis, A. N., Jun 2022, In: BJU international. 129, 6, p. 768-776 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Trial-based Cost-effectiveness Analysis of an Immediate Postoperative Mitomycin C Instillation in Patients with Non–muscle-invasive Bladder Cancer

    Hentschel, A. E., Blankvoort, C. J., Bosschieter, J., Vis, A. N., van Moorselaar, R. J. A., Bosmans, J. E. & Nieuwenhuijzen, J. A., 1 Mar 2022, In: European Urology Open Science. 37, p. 7-13 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Radiotherapy is the Preferred Primary Tumor Treatment in Oligometastatic Prostate Cancer

    van Moorselaar, R. J. A., Hulshof, M. C. C. M. & Pieters, B. R., 1 Jan 2022, In: European Urology Open Science. 35, p. 70-71 2 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  9. Surgical outcomes and proposal for a treatment algorithm for urethral strictures in transgender men

    de Rooij, F. P. W., Peters, F. R. M., Ronkes, B. L., van der Sluis, W. B., Al-Tamimi, M., van Moorselaar, R. J. A., Bouman, M-B. & Pigot, G. L. S., Jan 2022, In: BJU international. 129, 1, p. 63-71 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Comparison of surgical outcomes and urinary functioning after phalloplasty with versus without urethral lengthening in transgender men

    de Rooij, F. P. W., van der Sluis, W. B., Ronkes, B. L., Steensma, T. D., Al-Tamimi, M., van Moorselaar, R. J. A., Bouman, M-B. & Pigot, G. L. S., 2022, (E-pub ahead of print) In: International Journal of Transgender Health.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Corrigendum to “Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study” (Urologic Oncology: Seminars and Original Investigations (2020) 38(9) (735.e17–735.e25), (S1078143920302519), (10.1016/j.urolonc.2020.05.022))

    Vernooij, R. W. M., Cremers, R. G. H. M., Jansen, H., Somford, D. M., Kiemeney, L. A., van Andel, G., Wijsman, B. P., Busstra, M. B., van Moorselaar, R. J. A., Wijnen, E. M., Pos, F. J., Hulshof, M. C. C. M., Hamberg, P., van den Berkmortel, F., Hulsbergen-van de Kaa, C. A., van Leenders, G. J. L. H., F€utterer, J. J., van Oort, I. M. & Aben, K. K. H., 2022, (E-pub ahead of print) In: Urologic oncology.

    Research output: Contribution to journalComment/Letter to the editorAcademic

Previous 1 2 3 4 5 6 Next

ID: 74407